GRCE
Grace Therapeutics·NASDAQ
--
--(--)
--
--(--)
GRCE fundamentals
Grace Therapeutics (GRCE) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.21 (YoY +12.50%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.21
+12.50%
Report date
Aug 12, 2025
EPS
Actual | -2.4 | -2.88 | -1.44 | -1.44 | -0.48 | -0.18 | -0.54 | -0.54 | -0.6 | -0.66 | -0.54 | -3.9 | -0.54 | -0.43 | -0.21 | -0.17 | -0.24 | -0.3 | -0.36 | 0.11 | -0.21 | ||||||||
Forecast | -2.7871 | -2.6467 | -1.92 | -1.92 | -0.48 | -0.78 | -0.74 | -0.84 | -0.28 | -0.26 | -0.23 | -0.35 | -0.265 | -0.37 | -0.335 | -0.2775 | -0.22 | ||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +13.89% | -8.81% | +25.00% | +25.00% | 0.00% | 0.00% | -12.50% | +30.77% | 0.00% | 0.00% | +27.03% | -364.29% | -92.86% | -65.38% | +8.70% | +51.43% | +9.43% | +18.92% | -7.46% | +139.64% | +4.55% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | -- | 81.00K | -- | -- | -- | -- | -- | -- | 0 | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Grace Therapeutics beat or miss consensus estimates last quarter?What is Grace Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Grace Therapeutics's revenue and profit?What is Grace Therapeutics's gross profit margin?What were the key takeaways from Grace Therapeutics’s earnings call?What is the revenue and EPS growth rate for Grace Therapeutics year over year?What is the market's earnings forecast for Grace Therapeutics next quarter?What were the key takeaways from Grace Therapeutics's earnings call?
